[Bioparox efficiency for recurrent bronchitis of frequently ill children with fungal and bacterial colonization of the nasopharynx].
T G
TG
Malanicheva
N V
NV
Ziatdinova
L F
LF
Akhmadieva
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001419:Bacteria / Q000254:growth & development* / Q000302:isolation & purification; D029481:Bronchitis, Chronic / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D015169:Colony Count, Microbial; D047630:Depsipeptides; D005260:Female; D005500:Follow-Up Studies; D005658:Fungi / Q000254:growth & development* / Q000302:isolation & purification; D005670:Fusarium; D006801:Humans; D007820:Laryngeal Mucosa / Q000382:microbiology*; D008297:Male; D009305:Nasopharynx / Q000382:microbiology*; D012008:Recurrence; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D047630:Depsipeptides; C014001:fusafungin